CareerCross uses cookies to enhance your experience on our websites. If you continue to view our sites without changing your browser settings, then it is assumed that we have your consent to collect and utilise your cookies. If you do not want to give us your consent, then please change the cookie settings on your browser. Please refer to our privacy policy for more information.
CareerCross uses cookies to enhance your experience on our websites. If you continue to view our sites without changing your browser settings, then it is assumed that we have your consent to collect and utilise your cookies. If you do not want to give us your consent, then please change the cookie settings on your browser. Please refer to our privacy policy for more information.
U-Medico offers cutting-edge analytical services to bring the quality of biopharmaceuticals to the world's highest level.
U-Medico Inc., a spin-out from Osaka University, is an analytical and research service provider of biopharmaceuticals and new modalities. We provide high-quality analytical and formulation development services for biopharmaceuticals, including antibodies and fusion proteins, as well as gene therapeutics, to more than 40 domestic and international clients annually. We provide comprehensive support to our clients from the drug discovery stage through drug development, submission, and post-approval, contributing to safe and reliable drug development.
Our strength is our world-leading analytical technology, extensive experience, and unique know-how in utilizing that technology. In particular, we have a strong background in unique and highly accurate biophysical characterization, including analytical ultracentrifugation (AUC), hydrogen/deuterium exchange mass spectrometry (HDX-MS), and particles and aggregates analysis. We have helped our clients solve problems in pharmaceutical development.
In formulation development services, we entered into a strategic partnership with Coriolis Pharma, a world-leading company in formulation research and development, to further improve our technologies. Technical collaboration is being promoted to realize innovative formulation development services.
Furthermore, in April 2022, U-Medico launched its Cell and Gene Therapy Unit to take responsibility for the future of pharmaceuticals. In recent years, gene therapy, in which therapeutic genes are introduced into the body to treat genetic diseases fundamentally, has been gaining attention. The unit will provide intensively world-class analytical and quality testing services to ensure the stable production of high-quality cell and gene therapies.
We listen sincerely to our clients' concerns and propose solutions and new opportunities. As an analytical expert, researcher, and consultant, we will accompany you on your drug development journey. We hope you will use our knowledge and experience in your business.